Typhoid Fever Treatment Guidelines
Ceftriaxone is the first-line treatment for typhoid fever due to its high efficacy and lower resistance rates, particularly in regions with high fluoroquinolone resistance. 1
First-Line Treatment Options
Ceftriaxone
- Recommended as first-line empiric treatment by the World Health Organization 1
- Dosage: 50-80 mg/kg/day for 7-10 days 1
- Advantages:
- High efficacy with reliable sensitivity patterns globally
- Suitable for severe infections or when oral therapy isn't possible
- Safe alternative during pregnancy 1
Azithromycin
- Excellent alternative first-line option 1
- Advantages:
Treatment Algorithm Based on Resistance Patterns
For fully sensitive strains:
- Azithromycin as first choice
- Alternatives: Fluoroquinolones, chloramphenicol, amoxicillin, trimethoprim-sulfamethoxazole 1
For multidrug-resistant strains:
- Fluoroquinolones (if susceptible) or cefixime
- Alternative: Azithromycin 1
For quinolone-resistant strains:
- Azithromycin or ceftriaxone
- Alternative: Cefixime 1
Important Treatment Considerations
- Treatment duration: Continue for 14 days to reduce relapse risk 1
- Expected response: Clinical improvement typically occurs within 48-72 hours; fever clearance time is usually <4 days with appropriate treatment 1
- Monitoring: Closely observe for clinical response, particularly when using cefixime which has higher failure rates (4-37.6%) compared to other options 1
Antimicrobial Resistance Concerns
- More than 70% of Salmonella typhi isolates imported to the UK are resistant to fluoroquinolones 1
- Ciprofloxacin is FDA-approved for typhoid fever but should be used with caution due to increasing resistance, particularly in South and Southeast Asia 2, 1
- Using ciprofloxacin discs alone to determine Salmonella typhi sensitivity is unreliable; the organism should also be sensitive to nalidixic acid on disc testing 1
Special Populations
- Pregnant women: Ceftriaxone is considered safe and particularly useful for severe infections 1
- Children: Azithromycin is preferred due to its safety profile; avoid fluoroquinolones when possible 1
Comparative Efficacy
- A Cochrane review found ceftriaxone to be an effective treatment for adults and children with enteric fever, with few adverse effects 3
- A randomized controlled trial comparing azithromycin and ceftriaxone in children showed high cure rates for both: 91% for azithromycin and 97% for ceftriaxone 4
- Gatifloxacin and azithromycin showed similar efficacy in a randomized controlled trial, with median fever clearance time of 106 hours in both treatment arms 5
Prevention
- Typhoid vaccination is recommended for travelers to endemic areas
- Proper hand hygiene and food safety practices are essential
- Avoid high-risk foods and beverages in endemic areas 1
Common Pitfalls to Avoid
- Using fluoroquinolones empirically without considering local resistance patterns
- Relying on the serological Widal test for diagnosis due to its poor sensitivity and specificity 1
- Using antimotility agents in patients with high fever or blood in stool 1
- Stopping treatment early, which can lead to relapse 1
- Using ciprofloxacin in areas with known high resistance rates